ABELDIA TAMEZ: Open Payments
NPI 1346006103 · REDLANDS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$544 in 25 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $544
Food & beverage: $544
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $127 |
| Vanda Pharmaceuticals Inc. | 4 | $118 |
| ABBVIE INC. | 4 | $63 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $44 |
| Alkermes, Inc. | 2 | $41 |
| Brainsway USA INC | 1 | $31 |
| E.R. Squibb & Sons, L.L.C. | 1 | $30 |
| Lundbeck LLC | 1 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $29 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
Products named: FANAPT, REXULTI, VRAYLAR, ABILIFY ASIMTUFII, TRINTELLIX, Deep TMS System, COBENFY, CAPLYTA.
Industry payments across CA — which companies pay providers there.
